CHM.CN Stock Surges 900% in May 2026 as Waverunner Capital Gains Momentum

CHM.CN stock exploded with a 900% gain on May 1, 2026, reaching C$0.05 per share on the CNQ exchange. Waverunner Capital Inc., a North Vancouver-based venture capital firm, is capturing investor attention with this dramatic price movement. The company recently rebranded from Chemistree Technology Inc. in June 2024 and now focuses on early-stage investments, PIPEs, and bridge financing across Europe and North America. With a market cap of C$37.2 million and 744 million shares outstanding, CHM.CN stock represents a high-volatility opportunity in the healthcare sector. Track CHM.CN on Meyka for real-time updates on this volatile mover.

CHM.CN Stock Price Action and Trading Volume

CHM.CN stock jumped from a previous close of C$0.005 to C$0.05, marking the explosive 900% surge in a single session. The stock traded at its day high and low of C$0.05, showing tight price action during regular market hours on May 1, 2026.

Average trading volume stands at 28,908 shares, though current session volume data remains unavailable. The 50-day moving average sits at C$0.0424, while the 200-day average is C$0.0481. Year-to-date performance shows the stock has recovered from its C$0.05 year low to match its current price, though it remains well below the C$0.10 year high set earlier.

Waverunner Capital Inc. Business Model and Investment Strategy

Waverunner Capital Inc. operates as a venture capital specialist targeting early-stage companies and growth opportunities. The firm invests in seed-stage startups, PIPEs (private investments in public equity), bridge financing, and recapitalizations across Europe and North America. CEO Karl Eric Kottmeier leads the company from its headquarters at 828 Harbourside Drive in North Vancouver, British Columbia.

The company seeks equity investments between C$500,000 and C$1 million in companies with enterprise values between C$2 million and C$5 million. Waverunner Capital deploys capital through its own balance sheet and personal capital, diversifying across renewable energy (wind and solar), plant-based wellness, and consumer-targeted biotechnology ventures. This diversified approach positions the firm to capture growth across multiple emerging sectors.

Financial Metrics and Valuation Concerns

CHM.CN stock shows significant financial headwinds reflected in negative key metrics. The company reports a negative EPS of -C$0.01 and a negative PE ratio of -5.0, indicating ongoing losses. Net income per share stands at -C$0.0595, while operating cash flow per share is -C$0.0046.

The current ratio of 0.097 raises liquidity concerns, suggesting the company holds only C$0.097 in current assets for every dollar of current liabilities. Book value per share is deeply negative at -C$0.1422, and the company carries C$0.0923 in interest debt per share. These metrics reflect the challenging financial position typical of early-stage venture capital firms with limited revenue generation and ongoing investment activities.

Market Sentiment and Technical Positioning

Meyka AI rates CHM.CN with a grade of B, suggesting a HOLD recommendation based on comprehensive analysis. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects both the company’s strategic positioning and its financial challenges.

The five-day performance shows a 400% gain, while the one-year change also reflects 400% appreciation. However, longer-term trends reveal weakness: the stock is down 80.4% over five years and 93.3% over ten years. These grades are not guaranteed and we are not financial advisors. The extreme volatility and negative fundamentals suggest this stock carries substantial risk for investors seeking stable returns.

Final Thoughts

CHM.CN stock’s 900% surge on May 1, 2026, reflects high-volatility trading rather than fundamental strength. Waverunner Capital Inc. operates in a challenging venture capital landscape with negative earnings, weak liquidity, and significant debt. While the company’s diversified investment strategy across renewable energy, wellness, and biotech shows promise, current financial metrics reveal ongoing losses and operational strain. The B grade from Meyka AI suggests a cautious HOLD stance. Investors should recognize that CHM.CN stock remains a speculative play suitable only for risk-tolerant portfolios. The dramatic price movement highlights the importance of conducting thorough due …

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.